Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
409
-
Total 13F shares, excl. options
-
52.9M
-
Shares change
-
-2.39M
-
Total reported value, excl. options
-
$6.55B
-
Value change
-
-$427M
-
Put/Call ratio
-
1.48
-
Number of buys
-
209
-
Number of sells
-
-187
-
Price
-
$123.96
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2018
489 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2018.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 409 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.9M shares
.
Largest 10 shareholders include Vanguard Group Inc (5.04M shares), FMR LLC (4.59M shares), BlackRock Inc. (4.14M shares), PUTNAM INVESTMENTS LLC (3.08M shares), JPMORGAN CHASE & CO (1.94M shares), Bank of New York Mellon Corp (1.45M shares), STATE STREET CORP (1.38M shares), TIAA CREF INVESTMENT MANAGEMENT LLC (1.35M shares), Boston Partners (1.32M shares), and RENAISSANCE TECHNOLOGIES LLC (1.15M shares).
This table shows the top 409 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.